Pulmonology

Pulmonary arterial hypertension can be associated with exposure to certain drugs, such as anorectic agents or selective serotonin reuptake inhibitors.

Ambrisentan may be an effective adjunctive therapy for patients with pulmonary arterial hypertension who inadequately respond to PDE5i monotherapy.

Ambrisentan may be an effective adjunctive therapy for patients with pulmonary arterial hypertension who inadequately respond to PDE5i monotherapy.

Researchers sought to determine if any serological biomarkers for PAH could be identified in patients with systemic lupus erythematosus.

The majority of patients with chronic obstructive pulmonary disease (COPD) in the general population experience changes in COPD exacerbation frequency over time.

Prevalence data for chronic thromboembolic pulmonary hypertension are limited and there are conflicting reports regarding its pathogenesis. In a recent study, researchers investigated estimated future...

A recent study evaluated the efficacy of magnetic resonance imaging measurements for assessing potential outcomes in patients with pulmonary arterial hypertension.

A swab test that can diagnosis respiratory infections quickly was found to reduce the length of hospital stay and improve influenza detection and treatment.

The American Association for Thoracic Surgery released new guidelines for the treatment of adult and pediatric patients with empyema.

Researchers evaluated the frequency and severity of bacterial exacerbations in patients with chronic obstructive pulmonary disease and coexisting bronchiectasis.